RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.020
EU - Europa 13.310
AS - Asia 6.450
SA - Sud America 795
AF - Africa 96
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 20
Totale 42.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.924
GB - Regno Unito 4.848
IT - Italia 3.612
CN - Cina 1.836
SG - Singapore 1.732
HK - Hong Kong 1.585
SE - Svezia 1.317
DE - Germania 781
BR - Brasile 709
RU - Federazione Russa 597
TR - Turchia 596
UA - Ucraina 593
FI - Finlandia 411
FR - Francia 283
BG - Bulgaria 237
KR - Corea 149
IN - India 123
NL - Olanda 120
IE - Irlanda 94
ID - Indonesia 93
BE - Belgio 78
RO - Romania 73
CA - Canada 61
VN - Vietnam 51
LT - Lituania 46
ES - Italia 42
IR - Iran 41
CH - Svizzera 33
PL - Polonia 28
ZA - Sudafrica 28
JP - Giappone 27
EG - Egitto 25
AU - Australia 24
AR - Argentina 23
IQ - Iraq 22
PK - Pakistan 22
CZ - Repubblica Ceca 20
IL - Israele 20
MY - Malesia 19
EC - Ecuador 17
GR - Grecia 17
AT - Austria 16
EU - Europa 16
MX - Messico 16
PT - Portogallo 16
BD - Bangladesh 15
AE - Emirati Arabi Uniti 13
UZ - Uzbekistan 13
MA - Marocco 12
CL - Cile 11
TW - Taiwan 11
CO - Colombia 10
HU - Ungheria 10
AZ - Azerbaigian 9
NZ - Nuova Zelanda 9
PE - Perù 8
DK - Danimarca 7
DZ - Algeria 7
SA - Arabia Saudita 7
SN - Senegal 7
TH - Thailandia 7
EE - Estonia 6
JM - Giamaica 6
KZ - Kazakistan 6
LK - Sri Lanka 6
BO - Bolivia 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
NO - Norvegia 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
AM - Armenia 4
BZ - Belize 4
LV - Lettonia 4
NP - Nepal 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
JO - Giordania 3
KH - Cambogia 3
KW - Kuwait 3
OM - Oman 3
RS - Serbia 3
YE - Yemen 3
AN - Antille olandesi 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
VE - Venezuela 2
AO - Angola 1
BH - Bahrain 1
Totale 42.708
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Santa Clara 2.707
Fairfield 2.348
Chandler 1.756
Woodbridge 1.635
Hong Kong 1.570
Ashburn 1.501
Jacksonville 1.262
Houston 1.057
Seattle 984
Singapore 962
Dearborn 953
Ann Arbor 918
Wilmington 912
Cambridge 795
Nyköping 775
London 605
Modena 526
Beijing 434
Hefei 364
Izmir 353
Princeton 249
Sofia 232
Eugene 219
Chicago 218
San Diego 209
Milan 187
Helsinki 175
Council Bluffs 164
New York 160
Moscow 158
Rome 142
Shanghai 126
Bologna 125
Des Moines 117
Redwood City 112
Seoul 100
Bremen 93
Falls Church 88
Fremont 87
Jakarta 83
Dublin 80
Los Angeles 80
Munich 75
Brussels 71
Reggio Emilia 67
Naples 55
The Dalles 53
São Paulo 52
Florence 49
Parma 48
Guangzhou 45
Boardman 44
Como 42
Nanjing 41
Turin 38
Norwalk 37
Catania 35
Tulare 33
Napoli 32
Frankfurt am Main 31
Bari 30
Dallas 28
Kunming 28
Jinan 26
Perugia 26
San Giuliano Milanese 26
Verona 24
Dong Ket 22
Belo Horizonte 21
Hounslow 21
Rio de Janeiro 21
Cairo 20
Ferrara 20
Nuremberg 20
Palermo 20
Phoenix 20
Padova 19
Toronto 19
Amsterdam 18
Columbus 18
Lauterbourg 18
Wuhan 18
Kilburn 17
Mountain View 17
Saint Petersburg 17
Zhengzhou 17
Changsha 16
Genoa 16
Indiana 16
Kocaeli 16
Turku 16
Brescia 15
Dongguan 15
Lappeenranta 15
San Francisco 15
Washington 15
Istanbul 14
Salerno 14
Salvador 14
Totale 31.034
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 451
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 430
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 353
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 320
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 310
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 289
Protein corona and nanoparticles: How can we investigate on? 284
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 280
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 278
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 275
Nanoparticle transport across the blood brain barrier 271
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 269
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 267
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 266
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 266
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 264
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 264
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 262
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 258
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 258
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 254
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 252
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 251
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 249
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 248
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 244
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 244
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 243
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 243
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 243
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 242
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 241
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 241
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 241
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 240
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 239
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 238
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 238
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 237
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 235
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 234
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 234
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 233
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 228
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 228
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 228
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 226
Functionalization of liposomes: microscopical methods for preformulative screening 225
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 224
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 223
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 223
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 223
Colloidal systems for CNS drug delivery 221
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 220
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 220
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 220
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 219
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 218
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 218
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 218
Cationic liposomes for gene transfection 216
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 216
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 215
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 215
Amphiphilic ion pairs of tobramycin with lipoamino acids 213
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 213
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 209
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 208
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 208
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 208
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 206
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 206
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 205
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 205
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 205
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 204
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat 203
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 202
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 202
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 201
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 200
Ketorolac tromethamine liposomes: Encapsulation and release studies 199
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 198
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 197
Polymeric nanoparticles for the drug delivery to the central nervous system 197
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 196
Brain targeting with polymeric nanoparticles: which administration route should we take? 195
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 194
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 193
Nanomedicine and neurodegenerative disorders: So close yet so far 193
Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing 192
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 190
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 189
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 189
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 189
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 189
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 187
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 187
Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System 187
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 187
Totale 23.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 0 0 0 0 0 0 0 272
2020/20215.893 848 233 449 524 492 362 487 701 255 899 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202510.853 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.105
Totale 43.132